CARDINAL HEALTH INC shareholders Q4 2022

About CARDINAL HEALTH INC

Cardinal Health Inc. is a leading healthcare services and products company that provides pharmaceuticals, medical products, and services to hospitals, pharmacies, and healthcare providers. The company operates in two segments: Pharmaceutical and Medical.

The Pharmaceutical segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals, over-the-counter healthcare products, and consumer health products. The Medical segment distributes medical, surgical, and laboratory products to hospitals, surgery centers, and physician offices.

Cardinal Health has a strong presence in the United States and operates in over 60 countries worldwide. The company has a market capitalization of over $15 billion and employs over 50,000 people.

In recent years, Cardinal Health has focused on expanding its product offerings and services to meet the changing needs of the healthcare industry. The company has made several strategic acquisitions, including the acquisition of Medtronic's Patient Care, Deep Vein Thrombosis, and Nutritional Insufficiency businesses.

Cardinal Health has also been recognized for its commitment to sustainability and corporate responsibility. The company has been named to the Dow Jones Sustainability Index for the past 10 years and has received numerous awards for its environmental and social initiatives.

Overall, Cardinal Health is a well-established and respected player in the healthcare industry, with a strong track record of growth and innovation. As the healthcare landscape continues to evolve, Cardinal Health is well-positioned to continue delivering value to its customers and shareholders.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.